Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

TPEX/4174 stock hub

TPEX/4174 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TPEX/4174is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

4.5B

Taipei Exchange

Market data

Live price

Current market quote for this ticker.

Current price

TPEX/4174

In the news

Latest news · TPEX/4174

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12P50 15.5P75 22.5

Trailing P/En/a

P25 14.4P50 18P75 31.9

ROE-59.8

P25 -16.2P50 0.3P75 9.8

ROIC-31.6

P25 -11.7P50 -0.2P75 8.8

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TPEX/4174 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

175

Groups with data

Currency

TWD

Showing 175 of 175 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Taiwan
Country code	TW
Enterprise value	TWD 4.6B
Exchange	Taipei Exchange
Financial currency	TWD
First seen	2026-05-10
Industry	Biotechnology
Isin	TW0004174008
Last refreshed	2026-05-10
Market cap	TWD 4.5B
Price	TWD 34.05
Price currency	TWD
Sector	Healthcare
Sic	2836
Symbol	tpex/4174
Website	https://www.obipharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-45.82%
EV Earnings	-2.26x
EV/FCF	-2.25x
EV/Sales	79.32x
FCF yield	-46.07%
P/B ratio	1.64x
P/S ratio	76.49x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	-132.36%
Gross Profit	TWD -77.5M
Net Income	TWD -2.1B
Net Income Growth Quarters	2%
Net Income Growth Years	1%
Pretax Margin	-3,857.41%
ROA	-29.87
Roa5y	-24.64
ROCE	-70.63
ROE	-59.82
Roe5y	-42.21
ROIC	-31.65

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-26.22%
Cagr1y	-56.37%
Cagr3y	-41.93%
Cagr5y	-32.78%
EPS Growth Years	0
Revenue Growth	-6.55x
Revenue Growth Q	80.44x
Revenue Growth Quarters	1x
Revenue Growth Years	0x
Revenue Growth3 Y	131.67x
Revenue Growth5 Y	-16.1x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	TWD 0.01
Assets	TWD 3.4B
Cash	TWD 1.2B
Current Assets	TWD 1.6B
Current Liabilities	TWD 350.6M
Debt	TWD 515.7M
Debt Equity	TWD 0.19
Debt FCF	TWD -0.25
Equity	TWD 2.7B
Interest Coverage	-165.1
Liabilities	TWD 696.1M
Long Term Assets	TWD 1.8B
Long Term Liabilities	TWD 345.6M
Net Cash	TWD 670.7M
Net Cash By Market Cap	TWD 14.97
Net Cash Growth	-74.46%
Net Debt Equity	TWD -0.25
Tangible Book Value	TWD 1.8B
Tangible Book Value Per Share	TWD 14
WACC	4.57

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	4.51
Inventory Turnover	5.9
Net Working Capital	TWD 219.4M
Quick ratio	4.3
Working Capital	TWD 1.2B
Working Capital Turnover	TWD 0.03

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-12.56%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-95.22%
1Y total return	-56.35%
200-day SMA	51.52
3Y total return	-80.43%
50-day SMA	37.41
50-day SMA vs 200-day SMA	50under200
5Y total return	-86.27%
All Time High	1,510
All Time High Change	-97.75%
All Time High Date	2015-12-18
All Time Low	31
All Time Low Change	9.84%
All Time Low Date	2026-04-24
ATR	1.47
Beta	0.11
Beta1y	0.22
Beta2y	0.38
Ch YTD	-36.94
High	35.5
High52	79.3
High52 Date	2025-05-13
High52ch	-57.06%
Low	33.7
Low52	31
Low52 Date	2026-04-24
Low52ch	9.84%
Ma50ch	-8.99%
Price vs 200-day SMA	-33.9%
RSI	41.63
RSI Monthly	26.13
RSI Weekly	26.07
Sharpe ratio	-2.08x
Sortino ratio	-2.65
Total Return	-12.56%
Tr YTD	-36.94
Tr1m	-12.69%
Tr1w	7.41%
Tr3m	-29.28%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	TWD -2.2B
Operating margin	-3,702.6

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	86,779,382%
Net Borrowing	11,031,000
Shares Insiders	6.44%
Shares Institutions	1.24%
Shares Out	131,580,000
Shares Qo Q	0.05%
Shares Yo Y	12.56%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	TWD -2.1B
Average Volume	643,074.5x
Bv Per Share	14.35
CAPEX	TWD -43.9M
Ch10y	-95.3
Ch1m	-12.69
Ch1w	7.41
Ch1y	-56.35
Ch3m	-29.28
Ch3y	-80.54
Ch5y	-86.49
Ch6m	-27.55
Change	-2.16%
Change From Open	-3.13
Close	34.8
Days Gap	1.01
Depreciation Amortization	165,525,000
Dollar Volume	14,914,070.2
Earnings Date	2026-05-13
EBIT	TWD -2.2B
EBITDA	TWD -2B
EPS	TWD -15.61
F Score	3
FCF	TWD -2.1B
FCF EV Yield	-44.42x
FCF Per Share	TWD -15.69
Financing CF	141,631,000
Fiscal Year End	December
Founded	2,002
Income Tax	TWD -2.7M
Investing CF	908,934,000
Is Primary Listing	1
Last Earnings Date	2025-11-11
Last Report Date	2025-12-31
Last Split Date	2026-01-27
Last Split Type	Reverse
Ma150	47.55
Ma150ch	-28.39%
Ma20	35
Ma20ch	-2.7%
Net CF	-972,720,000
Next Earnings Date	2026-05-13
Open	35.15
Position In Range	19.44
Ppne	994,294,000
Price Date	2026-05-08
Ptbv Ratio	2.43
Relative Volume	0.68x
Revenue	58,575,000x
SBC By Revenue	54.2x
Share Based Comp	31,747,000
Tax By Revenue	-4.65x
Tr6m	-27.55%
Volume	438,005
Z Score	3.49

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does TPEX/4174 pay a dividend?

Capital-return profile for this ticker.

Performance

TPEX/4174 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TPEX/4174?

Insider, institutional, and short-interest positioning.

Institutional ownership

+1.2%

Share of float held by funds and institutions

Insider ownership

+6.4%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+12.6%

Negative means the company is buying back shares.

Technical

TPEX/4174 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

41.6

Neutral momentum band

Price vs 200-day MA

-33.9%

50/200-day relationship not available

Beta (5Y)

0.11

Less volatile than the market

Sharpe ratio

-2.08

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TPEX/4174

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tpex/4174 stock rating?

tpex/4174 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tpex/4174 analysis?

The full report lives at /stocks/tpex/4174/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tpex/4174?

The latest report frames tpex/4174 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tpex/4174 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.